<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04227158</url>
  </required_header>
  <id_info>
    <org_study_id>Uhyogo4</org_study_id>
    <nct_id>NCT04227158</nct_id>
  </id_info>
  <brief_title>The Association Between the Distributions MCH and RBC, and Mortality in Hemodialysis Patients</brief_title>
  <official_title>The Association Between the Distributions MCH and RBC, and Mortality in a Cohort of Chronic Hemodialysis Patients: a 3-year Retrospective Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Hyogo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Hyogo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients were classified into two groups based on the values of MCH and RBC, patients with&#xD;
      MCH ≥30 pg but &lt;35 pg and RBC ≤350×104/μL; and MCH &lt;30 pg and RBC &gt;350×104/μL. Associations&#xD;
      between all-cause mortality and the distributions of MCH and RBC were assessed by&#xD;
      Kaplan-Meier curves and Cox proportional hazards regression model.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Hb levels generally provides the value of RBC and iron status because mean corpuscular&#xD;
      hemoglobin MCH is derived from the Hb divided by RBC. MCH depends on the size and&#xD;
      concentration of erythrocytes. Thus, the value of RBC and MCH depend on dose of ESA and iron,&#xD;
      respectively. Guidelines for Renal Anemia in Chronic Kidney Disease of 2015 Japanese Society&#xD;
      for Dialysis Therapy recommend administration hemoglobin (Hb) levels ≥10 g/dL but &lt;12 g/dL in&#xD;
      dialysis patients.Patients whose Hb levels is maintained at 10 to 12 g/dL, Hb levels is&#xD;
      widely distributed when divided into RBC and MCH. Therefore, the investigators examined the&#xD;
      prognosis of life in the distribution of MCH and RBC.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 20, 2020</start_date>
  <completion_date type="Actual">August 20, 2020</completion_date>
  <primary_completion_date type="Actual">August 20, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival rate between high or low RBC group (all cause death)</measure>
    <time_frame>three years (retrospectively)</time_frame>
    <description>Survival curves for 3-year survival, based on all available follow-up data, will perform with the use of Kaplan-Meier estimates and will be compared between groups with the use of the log-rank test, and used Holm's method as post hoc.</description>
  </primary_outcome>
  <enrollment type="Actual">437</enrollment>
  <condition>Renal Anemia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients has undergone maintenance Hemodialysis for &gt;1 year.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients will be controlled with hemoglobin levels between ≥10 g/dL and &lt;12 g/dL and&#xD;
             had undergone maintenance HD for &gt;1 year.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients will be excluded if they have peritoneal dialysis combined with HD, do not&#xD;
             have records of laboratory investigations during this period, or are transferred to&#xD;
             another hospital or lost to follow-up.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yuko MIZUNO, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of Hyogo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Graduate School of Applied Informatics, University of Hyogo</name>
      <address>
        <city>Kobe</city>
        <state>Hyogo</state>
        <zip>650-0047</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>January 9, 2020</study_first_submitted>
  <study_first_submitted_qc>January 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 13, 2020</study_first_posted>
  <last_update_submitted>November 2, 2020</last_update_submitted>
  <last_update_submitted_qc>November 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Hyogo</investigator_affiliation>
    <investigator_full_name>Yoshihiro Tsuji</investigator_full_name>
    <investigator_title>visiting researche, Yoshihiro Tsuji</investigator_title>
  </responsible_party>
  <keyword>red blood cell</keyword>
  <keyword>mean corpuscular hemoglobin</keyword>
  <keyword>hemoglobin</keyword>
  <keyword>Hemodialysis patients</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

